ERBB2 and triple-negative breast carcinoma: As a highly heterogeneous malignant tumor, IDBC included four main molecular subtypes including Luminal A, Luminal B, epidermal growth factor receptor 2 (HER2)-enriched, and triple-negative breast cancer (TNBC) (5, 6).